Business Context and Reporting Period
This Form 8-K reports the results of the Kestra Medical Technologies, Ltd. 2025 Annual General Meeting of Shareholders held on September 3, 2025. The company is incorporated in Bermuda and trades on The Nasdaq Stock Market LLC under the symbol KMTS.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Shareholder participation was high, with 48,835,102 shares voted, representing approximately 95% of the 51,348,656 shares outstanding as of the July 7, 2025 record date. The following proposals were submitted and approved:
- Proposal 1 (Election of Directors): Shareholders elected Conor Hanley and Elizabeth Kwo as Class I directors. Both nominees received over 43 million votes in favor, with approximately 3.6 million votes against each.
- Proposal 2 (Ratification of Auditors): Shareholders ratified the appointment of PricewaterhouseCoopers as the independent registered public accounting firm for the fiscal year ending April 30, 2026. The proposal passed with 48,814,793 votes for and only 5,444 votes against.
- Proposal 3 (Employee Stock Purchase Plan): Shareholders approved the 2025 Employee Stock Purchase Plan. The proposal received 45,801,106 votes for and 975,504 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting outcomes.
Key Facts for Investor Verification
- Verify the total number of shares outstanding (51,348,656) and the high voting participation rate (95%) as of the record date.
- Confirm the tenure of the newly elected directors, Conor Hanley and Elizabeth Kwo, which extends until the 2028 annual meeting.
- Note the significant margin of approval for the ratification of PricewaterhouseCoopers as the independent auditor.
- Review the terms of the newly approved 2025 Employee Stock Purchase Plan in subsequent filings or the proxy statement.